When cardiac
complaints occur
in the absence
of organic findings,
underlying
anxiety may be
one factor
The influence of anxiety on heart function
Excessive anxiety is one of a combina-tion of factors that may trigger a series of
maladaptive functional reactions which can
generate further anxiety. Often involved in
this vicious circle are some cardiac arrhyth-mias, paroxysmal supraventricular tachycar-dia and premature systoles. When these
symptoms resemble those associated with
actual organic disease, the overanxious
patient needs reassurance that they have no
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ataxia or oversedation, increasing gradually as needed and tolerated. Not recommended in children under six. Though generally not recommended, if
combination therapy with other psychotropics seems indicated, carefully
consider individual pharmacologic effects, particularly in use of potentiating
drugs such as MAO inhibitors and phenothiazines. Observe usual precautions

organic basis and that reduction of exces,
sive anxiety and emotional overreaction
would be medically beneficial.
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of effect or need for increase in dosage. (See
summary of prescribing information.) If
cardiovascular drugs are necessary, Librium
is used concomitantly whenever anxiety is a
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cautions.) Librium should be discontinued
when anxiety has been reduced to appropri,
ate levels.
in presence of impaired renal or hepatic function. Paradoxical reactions
(e.g., excitement, stimulation and acute rage) have been reported in psychiatric patients and hyperactive aggressive children. Employ usual precautions
in treatment of anxiety states with evidence of impending depression; suicidal
tendencies may be present and protective measures necessary. Variable effects
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drug and oral anticoagulants; causal relationship has not been established
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in chronic pain: continued relief without risk of tolerance
Though Talwin® Tablets can be
compared to codeine in analgesic
efficacy, Talwin is not subject to
narcotic controls. For patients who
require potent analgesia for prolonged
periods, Talwin can provide consistent,
long-range relief, with fewer of the
consequences you've come to expect
with narcotic analgesics.

• Comparable to codeine In analgesic efficacy: one 50 mg.
Talwin Tablet appears equivalent In analgesic effect to 60 mg.
(1 gr.) of codeine. Onset of significant analgesia usually
occurs within 15 to 30 minutes. Analgesia is usually maintained for 3 hours or longer.
• Tolerance not a problem: tolerance to the analgesic effect
of Talwin Tablets has not been reported, and no significant
changes in clinical laboratory parameters attributable to the
drug have been reported.
• Dependence rarely a problem: during three years of
wide clinical use, only a few cases of dependence have been
reported. In prescribing Ta/win for chronic use, the physician
should take precautions to avoid increases in dose by the
patient and to prevent the use of the drug in anticipation of
pain rather than for the relief of pain. (See last page for a
complete discussion of Warnings under Brief Summary.)
• Generally well tolerated by most patients: infrequently
cause decrease in blood pressure or tachycardia; rarely cause
respiratory depression or urinary retention; seldom cause diarrhea or constipation. If dizziness, lightheadedness, nausea or
vomiting are encountered, these effects may decrease or disappear after the first few doses. (See last page of this advertise- .
ment for a complete discussion of Adverse Reactions and a Brief
Summary of other Prescribing Information.)
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Indications: For the relief of moderate to severe pain.
Contraindication: Talwin should not be administered to patients who
are hypersensitive to it.
Warnings: Drug Dependence. There have been instances of psychological and physical dependence on parenteral Ta/win in patients with
a history of drug abuse and, rarely, in patients without such a history.
Abrupt discontinuance following the extended use of parenteral Ta/win
has resulted in withdrawal symptoms. There have been a few reports
of dependence and of withdrawal symptoms with orally administered
Ta/win. Patients with a history of drug dependence should be under
close supervision while receiving Ta/win orally.
In prescribing Ta/win for chronic use, the physician should take precautions to avoid increases in dose by the patient and to prevent the
use of the drug in anticipation of pain rather than for the relief of pain.
Head Injury and Increased /ntracranial Pressure. The respiratory depressant effects of Talwin and its potential for elevating cerebrospinal
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injury, other intracranial lesions, or a preexisting increase in intracranial pressure. Furthermore, Talwin can produce effects which may
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Usage in Pregnancy. Safe use of Talwin during pregnancy (other than
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delivering premature infants.
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acute CNS manifestations may recur.
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Precautions: Certain Respiratory Conditions. Although respiratory depres0sion has rarely been reported after oral administration of Talwin,
the drug should be administered with caution to patients with respiratory depression from any cause, severe bronchial asthma and other
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Impaired Renal or Hepatic Function. Decreased metabolism of the
drug by the liver in extensive liver disease may predispose to accentuation of side effects. Although laboratory tests have not indicated that
Talwin causes or increases renal or hepatic impairment, the drug
should be administered with caution to patients with such impairment.
Myocardial Infarction. As with all drugs, Talwin should be used with
caution in patients with myocardial infarction who have nausea or
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Biliary Surgery. Until further experience is gained with the effects of
Talwin on the sphincter of Oddi, the drug should be used with caution
in patients about to undergo surgery of the biliary tract.

Patients Receiving Narcotics. Talwin is a mild narcotic antagonist.
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daily treatment of narcotic dependence, have experienced mild withdrawal symptoms after receiving Talwin.
CNS Effect. Caution should be used when Talwin is administered to
patients prone to seizures; seizures have occurred in a few such
patients in association with the use of Talwin although no cause and
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Duration of Therapy. Patients with chronic pain who have received
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symptoms even when administration was abruptly discontinued (see
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INTRODUCTION
The 45th Annual McGuire Lecture Series has
been devoted to the subject of Immunology and the
Rheumatic Diseases. In this two-day period, 22
outstanding physicians in the field of immunology
and rheumatology brought an up-to-date overall
concept in the field of rheumatic diseases. Subjects
included not only aspects of pathogenesis but also
modern laboratory methods in the diagnosis of
various connective tissue diseases. The remedial
surgical approaches for prevention of pain and disability in rheumatoid arthritis were discussed from
a practical viewpoint. This symposium was sponsored in part by the Virginia Chapter of the Arthritis Foundation as well as the Department of Continuing Education at the Medical College of Virginia.
Because of the numerous papers submitted, it was
decided by the editorial board to devote two issues
of the MCV/ Q to this series, which will include
many of the papers presented at the symposium.
This year our McGuire Lecturer was Morris
Ziff, M.D., Ph.D. , Professor of Internal Medicine
at the University of Texas Southwestern Medical
School in Dallas . Dr. Ziff is a world-recognized
authority on immunology and connective tissue
diseases. He is a past president of the American
Rheumatism Association, recipient of the Heberden
Medal awarded by the Heberden Society of London,
distinguished Alumni Lecturer at the New York
University and the first Walter Bauer Lecturer at
the Massachusetts General Hospital. As Dr. Toone
so aptly remarked in his introduction, "Dr. Ziff
has the ability to be firm without rancor, to use
quiet humor to establish a point and above all,
pre-eminent prestige without a trace element of
arrogance." The first lecture which he delivered was
entitled "Immunological Aspects of Rheumatoid
Arthritis" and the second was "Viruses and the
Connective Tissue Diseases."
The latter will be included in the second issue
of the MCV / Q along with other papers in the
fields of juvenile rheumatoid arthritis, ankylosing
spondylitis, infectious arthritis and the more recent
aspects of antigenic determinants associated with
ankylosing spondylitis, psoriatic spondylitis and
Reiter's syndrome.
ROBERT IRBY, M.D.

Professor of Medicine
Department of Medicine
Medical College of Virginia
Virginia Commonwealth University
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Modern Immunology: Cells and Molecules* **
FRANKLIN MULLINAX, M. D.
Associate Professor of Medicine, Division of Connective Tissue
Diseases, Medical College of Virginia, Health Sciences Division of
Virginia Commonwealth University, Richmond

In this presentation I shall discuss 1) some
historical highlights in the field of immunology; 2)
the molecules of immunity, pa_rticularly the immunoglo bulins; and 3) the cells of immunity, particularly the immunocytes. This presentation may
provide a background for subsequent articles.
· Some Historical Highlights (Tables 1 and 2).
From its origins, immunology has been closely associated with infectious diseases, a bias from which we
are only now escaping. In the work of early investigators, we can see the clear demonstrations that
1) immunity is important in prevention of disease;
2) there are humoral and cellular phases of the
immune response; and 3) immune reactions can
themselves produce disease.
Edward Jenner (1749-1823) and Vaccination.
Systematic studies by this quiet scholarly country
physician established that inoculation with cowpox
pustules produced immunity to smallpox. The practice of inoculation or variolation had existed in the
Orient from early times. Material from the vesicle
or pustule of an active case of smallpox was inoculated into the. skin in order to produce a mild and '·
immunizing attack of smallpox. The value of this '
method was clearly documented in Benjamin Franklin's pamphlet of 1759, "Some account of the
success of inoculation for the smallpox in England
and America." Jenner proved that the much more
innocent inoculation with cowpox pustules was also
successful. During his studies he also discovered
that viruses can be attenuated and that an accele-

* Presented by Dr. Mullinax at the 45th Annual McGuire
Lecture Series, November 8, 1973, at the Medical College
of Virginia, Richmond.
**This is publication No. 67 from the Charles W.
Thomas Arthritis Fund.
MCV QUARTERLY 10(1): 9-12, 1974

rated response occurs in previously immunized
persons. His was the first account of an allergic
reaction in the skin.
Louis Pasteur (1822-1895) and the First Heroic
Phase of Immunology. In his thinking, Louis Pasteur was against the temper of his times. Antivitalism was dominant. Liebig and other prominent
scientists had no use for the animalcules postulated
to explain the origin of disease and fermentation.
They were wrong, however, and the germ theory
rose again with Pasteur's studies of the souring of
milk. His work followed a natural path from studies
of crystals to studies of diseases of wirte and silkworms, to studies of diseases of man, culminating
in immunization and prevention of disease. The
studies of chicken cholera revealed that the microbe
that kills is the one that immunizes and that the
microbe may be attenuated. They suggested to him
the possibility of attacking diseases of man. Finally,
the renowned studies of rabies led to inoculation
of young Joseph Meister on July 6, 1885 with the
first and least virulent of his rabies vaccines. Joseph
survived the series of injections and became the
gatekeeper at the Pasteur Institute.
Pasteur's experiments on immunization were
followed by a great outpouring of studies of immunology with concurrent deveiopment of biologic and
chemical concepts of immunity. On the biological
side, Eli Metchnikoff, the wild Russian, migrated
to Pasteur's laboratory and championed the nonspecific and the cellular aspects of immunity. While
looking through his microscope, Metchnikoff saw
cells engulfing particles and became the primary
discoverer of phagocytosis as a defense mechanism.
Koch, also at the Pasteur Institute, showed that
whereas the first intradermal injection of tubercle
9
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TABLE 1
JMMUNOBIOLOGY

May 14, 1796

Edward Jenner established vaccination.

July 6, 1885

Louis Pasteur injected attenuated rabies
virus into Joseph Meister.

1882

Eli Metchnikoff and phagocytosis.

To 1905

Bordet,Arthus, vonPirquet, Schick, Ehrlich.

1953

Owen, Medawar and Burnet. Immunologic
tolerance.

bacilli evoked no response in guinea pigs, the second injection led to an inflammatory reaction, thus
initiating the concept of delayed hypersensitivity
or cellular immunity.
The Pasteur Institute was also involved in chemical studies of immunity. After Pasteur's work on
bacteria as the cause of diseases of wine, beer, and
later, of man, attention turned to diphtheria. Roux
expected that this devastating disease would be
characterized by massive bacterial proliferation; but
only a few bacilli could be isolated from the iocal
lesion. Something else must be responsible for the
toxicity of diphtheria. This line of investigation led
to the isolation of bacterial toxins, the preparation
of antitoxins, identification of the antitoxins as serum

TABLE 2
IMMUNOCHEMISTRY

October 30, 1845 William Macintyre examined the urine
of his patient, Mr. Macbee, who had
myelomatosis.

proteins, prophylactic use of antitoxin-containing
sera, and description of serum sickness. This phase
of research extended through 1905 with the publication of Serum Sickness by von Pirquet and Schick.
Forgetting many other important contributions, we
may tum to 1953 and the development by Owen,
Medawar, and Burnet of the concept of immunologic tolerance, another landmark in the biology of
immunity.
The Chemistry of Immunity. On October 30,
1845 a practicing physician, William Macintyre,
examined the urine of his patient, Mr. Macbee,
who had the disease now known as multiple myeloma. The peculiar reactivity of . his urine-a precipitate formed on warming and dissolved with boiling--led Dr. Macintyre to consult with Dr. Henry
Bence Jones. More than a hundred years later,
studies of the Bence Jones proteins ushered in a
second heroic phase of immunology. Bence Jones
proteins and serum monoclonal proteins have proved
to be a Rosetta stone of immunology.
In 1900 Karl Landsteiner discovered blood
group antigens and their corresponding antibodies.
His chemical studies, particularly with low molecular
weight haptens, set the stage for quantitative immunochemistry, developed by Heidelberger and
Kabat, and by Marrack, from the 1920's through
the 1950's. The discovery of the LE cell by Hargraves in 1948 was important because it led to
detailed studies of the chemical basis of apparent
autoimmune reactions. Early in the 1960's the work
of Edelman, Porter, Putnam, and others gave the
central focus of immunology on the now familiar
four-chain structure of an antibody monomer.
The Immunoglobulins. It is fortunate that the
simple technique of paper or cellulose acetate electrophoresis provides a rather complete separation

1890

Roux and Behring identified toxiris and
antitoxins.

1900

Landsteiner described blood group antigens and antibodies.

1920

Beginnings of quantitative immunochemistry with Heidelberger, and later,
Kabat and Marrack.

lgG-The main antibody class.

1948

Hargraves described the LE cell.

IgM-Macroglobulins.

1%0's

Fundamental discoveries of antibody
structure: Putnam, Porter, Edelman,
Hood, Dreyer.

JgD-?

TABLE 3
THE IMMUNOGLOBULINS

lgA-Antibody, especially in secre!ions.

lgE-Skin sensitizing antibody.
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of the antibodies. Most antibodies are in the yglobulin fraction and most y-globulins are antibodies.
More sophisticated techniques, particularly immunoelectrophoresis, reveal that some antibodies are in
other electrophoretic fractions and that there are
at least five classes of antibodies. These are the
immunoglobulins: IgG, lgA, IgM, lgD, and lgE
(Table 3). IgG is the main circulating immunoglobulin; IgA is prominent in secretions (tears,
saliva); lgM is generally a pentameric molecule,
restricted to the intravascular space and particularly effective biologically; IgD is a minor component of uncertain function; and lgE is present in
trace amounts but is extremely important because
it mediates immediate ( anaphylactic) hypersensitivity.
A diagrammatic representation (Fig. 1) of the
IgG molecule reveals that it has four chains-two
light chains and two heavy chains. The light chains
(Bence Jones proteins) are often produced in excess by plasma cells. Large amounts of these proteins
are excreted by many patients with myelomatosis.
Variations in amino acid sequences in the first part
of the light and heavy chains provide variations in
antibody specificity, that is, antibody diversity. Further structural studies reveal that the light chains
have two and the heavy chains have four disulfide
domains, homologous parts of the molecule which
rotate almost independently. Another way to examine the molecule is literally by looking at it.
High-resolution electron micrographs reveal the
lgG molecules to be Y-shaped with the two antigen
binding sites on the forks. lgM molecules have five
monomer Y's around a central core.

{Light chain (Bence Jones protein)

s

Heavy chain

f

s

s
s
s

Antigen binding site

Fig. I-Diagrammatic representation of an lgG molecule.
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Fig. 2-Electron micrograph of a plasma cell from a human
kidney graft removed because of impending rejection. Note
the prominent endoplasmic reticulum. (Courtesy of Dr.
W. J. S. Still, Medical College of Virginia).

These immunoglobulins are the mediators of
humoral immunity and are produced by cells of
the plasma cell series. These secretory cells (Fig. 2)
have an elaborate endoplasmic reticulum which
contains the organelles concerned with synthesis
and secretion of plasma proteins.
Cellular Immunity. A different group of cells,
activated lymphocytes, mediate cellular immune reactions. Such an activated lymphocyte is see·n in
figure 3. Upon antigenic stimulation, lymphocytes
mediating cellular immune reactions enlarge, divide,
and provide mediators, lymphokines, which incite
local inflammatory reactions. Cellular immunity is
largely responsible for immunity against intracellular
parasites, contact drug allergy, graft rejection, and
tumor rejection. A typical reaction of cellular immunity is the reaction of delayed hypersensitivity,
such as the tuberculin reaction.
Observations on patients with immunodeficiency

12
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Fig. 3-Electron micrograph of a transformed lymphocyte
in the splenic white pulp of a lethally x-irradiated mouse
36 hours after injection of rat small lymphocytes. Note the
absence of endoplasmic reticulum. This rat lymphocyte
became transformed after contact with immunologically
foreign mouse tissue. It is now prepared to provide a line
of cells mediating the graft-versus-host response. (Courtesy
of Dr. J. L. Gowans, Oxford University, and publishers,
S. Karger, Basel/New York).1

cell precursors (B cells) are produced in the bursa
of Fabricius, an organ near the cloaca. In man, the
- corresponding tissues are not clearly identified. The
marrow itself or gut-associated lymphoid tissue may
be involved. The second breeder site is the thymus.
It provides T lymphocytes and cellular immunity.
Interrelations of T and B cells are complicated and
important, as some of the following presentations
will indicate.
In this brief overview, I have presented some
historical highlights of chemical and biologic approaches to immunology. The chemical approaches
lead to our current detailed picture of immunoglobulin structure. The biologic studies lead to the
concept of a two-component system, B and T cells,
mediating humoral and cellular immunity. These
chemical and biologic findings provide a framework
for analyzing not only basic immunology but also
clinical diseases. For completion, I should briefly
mention the scavenger macrophages-probably important in antigen processing; the complement system-important in amplifying the effects of an
immune response; the kinins and other molecules
of inflammation; and the polymorphonuclear leukocytes and other apparently nonspecific defenders.
The Immunologic Mosaic. The outlines of modern immunology are now discernible. The resultant
picture is like a mosaic rather than a photograph. We
are now at the exciting point where the form is
emerging.

BONE MARROW

!

Stem4 Cells

~

~URSA-LIK~ TISSUES!

Thymic (T) tymphocytes

diseases and experiments in animals have given
rise to the concept of two different systems that
mediate humoral and cellular immunity (Fig. 4).
According to this view, stem cells from the bone
marrow migrate to breeding sites for the cells of
the two types of immunity. In the chicken, plasma
1 Reprinted by permission from Gowans JL, McGregor
DD : The immunological activities of lymphocytes. Progress
in Allergy 9: 1, 1965.

i

Bursa! (B) Lymphocytes

Lymph nodes, spleen, Peyer's patches
J, + Antig.en (Ag)

Ag-specific transformed lymphocytes

"'lJ

Proliferation of thymic- dependent and

antigen-sper '. fic lymphocytes in para-

cortica l areas -+Ag- specific cellular
immunity (delayed hype rsensitivity)
(cell-bound antibody) and immunologic
memory .

.!~
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Fig. 4-Bone marrow - thymus - bursa interrelations. The
bursa-like tissues in man may be either the bone marrow
itself or certain gut-associated lymphoid tissues (GALT).

Recent Advances in Synovial Fluid Analysis*
DUNCAN S. OWEN, JR., M. D., F. A. C. P.
Associate Professor of Medicine, Division of Connective Tissue
Diseases, Medical College of Virginia, Health Sciences Division of
Virginia Commonwealth University, Richmond

Synovial fluid analysis is a frequently ignored
examination except in suspected cases of septic conditions. It has been shown that it is an extremely
valuable procedure in making rapid and accurate
diagnoses in many types of joint diseases.
Table 1 illustrates the findings in ten separate
joint states. The gross appearance, "wet-prep"
microscopic examination, leukocyte count and sugar
content are procedures that are extremely important
and can be performed with a paucity of equipment.
We have not found the mucin-clot test or protein
content to be very helpful. Of course, if infection
is a possibility, Gram's stain and appropriate cultures
should be instituted. It should be remembered, however, that only 25-30% of the cases of gonococcal
arthritis will be associated with a positive Gram's
stain or culture. The culture yield may possibly
improve with the increasing use of Thayer-Martin
media. The anticoagulant should be either heparin
or EDTA instead of oxalate because the examiner
may confuse oxalate crystals with urate or pyrophosphate crystals.
Cell Counting. The white blood cell count is of
particular importance in suspected septic conditions.
Methods have been outlined in detail in an excellent book by Ropes and Bauer. The fluid should
.be collected in an anticoagulant tube. The diluent
should be··physiologic saline because acetic acid will
cause precipitation of mucin and make an accurate
count practically impossible. The addition of
methylene blue to the diluent will help differentiate
the cell types. If the fluid is hemorrhagic, a hypo-

* Presented by Dr. Owen at the 45th Annual McGuire
Lecture Series, November 8, 1973, at the Medical College
of Virginia, Richmond.
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tonic diluent of 0.3% sodium chloride can be tried
which theoretically will disrupt the red blood cells
but not the nucleated cells.
A differential white count using Wright's stain
is performed in the same manner as a peripheral
blood smear. If the total white blood count in the
synovial fluid is less than 5,000/mm3 , it is best to
centrifuge the fluid at 2,000-3,000 rpm for ten
minutes. The supernatant is then removed arid
physiologic saline added to the sediment until. the
original volume is obtained. The solution should
then be recentrifuged which will remove most of
the mucin. The sediment can then be easily smeared
on a slide, air dried, and stained. In cases of systemic lupus erythematosus (SLE), the .LE cell may
be seen.
Glucose. The glucose value of normal synovial
fluid usually parallels that of serum. The results are
of greater value if the patient has been fasting for
about six hours. It is even possible for normal
synovial fluid sugar to be higher than that of the
serum for several hours postprandially.
In any suspected septic joint condition, a glucose determination should always be performed. We
have found the glucose levels to be low in almost all
cases of septic arthritis observed at the Medical
College of Virginia during the past seven years. It
is important to have the glucose level determined
immediately after aspiration. Because of the glucolytic action of white cells, falsely low levels may
be observed in cases of rheumatoid arthritis and
gout, for example, if the white cell count of the
fluid is high and the fluid is not tested for one or
more hours. The falsely low sugar level can also
be prevented by placing the fluid to be tested in a
sodium fluoride tube. A synovial glucose of 50 mg %
13
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TABLE 1
SYNOVIANALYSIS

Disease

Mucin
Appearance Clot Viscosity

Leukocytes
per mm 3

Sugar: serumsynovial difference
(mg/lOOml)

Crystals

Comment

Normal

Clear,
amber

Good

High

<200
<25% polys

<10

None

Gouty
Arthritis

Milky or
yellow

Poor

Low

15,000+
70% polys

10±

Sodium
urate

Pseudogout

Turbid,
amber, or
yellow

Fair to Fair or
Poor
Low

25,000±
90% polys±

10±

Calcium
Few-to-many weakly
pyrophosphate positive intra- and extracellular calcium pyrophosphate crystals.

Rheumatoid
Arthritis

Turbid,
amber to
light green

Poor

Low

15,000+
70% polys

25

Occasional
cholesterol

WBC inclusions frequently present.
Rheumatoid factor
usually present.

Septic
Arthritis

Very turbid, Poor
gray

Low

70,000±
90% + polys

70

None

Culture positive in only
20-30% of GC cases.

Tuberculous
.(\rthritis

Turbid,
amber, or
yellow

Poor

Low

30,000±
60%± polys

so+

None

Biopsy frequently
helpful.

Osteoarthritis

Clear,
amber

Good

High

1000±
10% polys

<10

None

Cartilage fibrils may
be present.

Acute
Traumatic
Arthritis

Bloody or
turbid

Good

High

<2000
<25% polys

<10

None

Occasional cartilage
fibril. Many RBC's.

Slightly
Systemic
turbid,
Lupus
Erythematosus amber

Good

High

3000±
<10% polys

10±

None

Examine for LE
cells.

Slightly
turbid,
amber

Good

Fair
to Low

15,000
50% polys

10±

None

Occasional WBC
inclusion

Rheumatic
Fever

less than fasting serum should be considered as
strongly indicating an infectious process until 'proved
otherwise.
"Wet Drop" Preparation Studies. The microscopic examination of a drop of fresh or anticoagulated synovial fluid may yield diagnostic information,
especially in cases of crystal deposition diseases
(gout and pseudogout). This examination is performed by placing a small drop of synovial fluid
on a glass slide, covering with a cover slip and
sealing the edges with clear fingernail polish. Only
a small drop is used to prevent individual cells from

Strongly negative birefringent intra- and extracellular urate crystals.

moving across the field of view. Sealing the slide
prevents the formation of artifacts while drying and
will preserve the specimen for one or more hours.
The synovial fluid findings in the crystal deposition diseases, gout (monosodium urate crystal deposition disease) and pseudogout (calcium pyrophosphate dihydrate crystal deposition disease), were
described in the early 1960's. The discovery and
identification of these crystals in synovial fluid,
using the compensated polarizing microscope, led
to great enthusiasm in making rapid and accurate
diagnoses of crystal-induced synovitis. Unfortunately,
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the compensated polarizing microscope is an expensive piece of equipment, which is not readily
available in the office of most physicians and it is
infrequently found in general hospitals.
Simple Polarization. A simple polarizing microscope can be made from an ordinary microscope
by inserting a polarizing filter below the condenser,
usually on top of the light source (the polarizer),
and using one filter above the objective, usually in
the barrel or above the eye piece (the analyzer).
The polarizer is then rotated until the darkest field
possible is obtained. The monosodium urate (MSU)
crystals usually appear as bright needles against
this black background. The calcium pyrophosphate
dihydrate ( CPPD) crystals usually appear in bright
monoclinic, triclinic, rectangular or rhomboid forms,
and may be quite difficult to differentiate from
MSU crystals in synovial fluid . Figure 1 illustrates
the placement of simple plastic polarizing filters
in a laboratory microscope.
Compensated Polarization. The compensated
polarizing microscope utilizes a first-order red filter,
the compensator, which is inserted between the
objective and the analyzer. The compensator retards
red light and the polarized background becomes
red instead of black. The axis of the line of slow
vibration of the compensator is then defined. The
MSU and CPPD crystals will be either yellow or
blue, depending upon their respective positions to
this axis. The MSU crystal is brightly yellow when
parallel to the axis and indicates that it is strongly
negatively birefringent. The CPPD crystal is faintly
blue when in this position, indicating weakly positive birefringence.
On occasion, both MSU and CPPD crystals
are noted in the same fluid indicating coexisting
disease. Previously injected adrenocorticosteroids,
oxalate anticoagulant, cholesterol crystals, and
scratches on the slide or coverslip should not be
confused with either MSU or CPPD crystals.
New and Simple Technique. We have found a
very adequate substitute for the first-order red filter
which can be used with an ordinary light microscope which has been adapted with simple polarizing
filters. One needs only a clean microscopic glass
slide and simple transparent cellophane tape. One
piece of the cellophane tape is carefully applied
to the top side of the slide and then another piece
of tape is applied over this. Wide tape is preferable
but two pieces of narrow tape carefully applied
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Fig. I-Illustration of simple plastic polarizing filters in
barrel of microscope (analyzer) and above light source
(polarizer) .

beside two other pieces is satisfactory. The microscope is then adapted for simple polarizing microscopy as previously described. (One may first wish
to focus on the material to be examined.) The
cellophane-taped slide is then placed over the
polarizer and carefully rotated until the background
is quite red. We have discovered that the long axis
of the taped slide substitutes amazingly well for
the axis of slow vibration of the first-order red
compensator. The examiner can theh mentally project the axis of the taped slide on the stage. Figure 2
illustrates the celiophane-taped slide on top of the
polarizer. With the stage arranged to permit free
movement of the "wet-prep" slide, the examiner
can then rotate the "wet-prep" slide and define
whether the observed crystals are negatively or
positively birefringent.
It should be emphasized that cellophane is
closely controlled for thickness in its manufacturing
process but not for its r~fractive index. Therefore,
there may be a different retardation with each supply
of cellophane tape. We have tested numerous
batches of cellophane tape. Approximately 50%
will give the red background and the other 50%
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a blue background. The interested examiner may
have to purchase a few rolls of tape until a satisfactory one is found.
The improvised compensated polarizing microscope techniques described above have been a
tremendous help in making a rapid and accurate
diagnosis of crystal-induced synovitis. Faculty,
housestaff, and students are encouraged to carry
polarizing filters and a cellophane-taped microscope
slide with them. A great deal of enthusiasm has been
expressed. For the first time, individuals are really
learning the true meaning of the planes of birefringence. In the past, many individuals memorized,
in preparation for written examination, which crystals were negatively or positively birefringent. It is
hoped that others will discover these techniques
to be helpful to them. Examiners will be greatly
helped in establishing theii: own personal techniques
by smearing some MSU crystals from a tophus on
a clean microscopic slide. They can then experiment
with the filters until the simple maneuvers are
mastered.
Ragocytes (RA cells, inclusion body cells,
raisin seed cells) in syriovial fluid of patients with
rheumatoid arthritis were originally described by
Dr. Joseph Hollander and associates. These cells

-a

POLARIZER

Fig. 2-Illustration of "cellophane tape compensator" above
the polarizer.

are leukocytes containing inclusion bodies. They
appear as dark granules under regular light microscopy at high dry magnification and as clear vacuo~
lated areas with phase microscopy. It was assumed
that these bodies were phagocytosed rheumatoid
factor and they were noted in from 5-95% of the
total leukocyte population of rheumatoid synovial
fluid . It was believed that phagocytosis of rheumatoid factor played a role in the pathogenesis of
rheumatoid arthritis in a similar fashion to the
phagocytosis of sodium utate crystals in the pathogenesis of gouty arthritis. This concept was supported
with the production of acute synovitis by the .injection of autologous yG-globulin into inactive joints
of patients with rheumatoid arthritis. Subsequent
studies have shown that the findings of these leukocyte inclusions are not specific for rheumatoid arthritis. They may be found in other types of inflammatory joint disease and may be scavengers which
have phagocytosed products of inflammation including y-globulins.
Osteoarthritis fluid may reveal a few-to-many
cartilage fibrils and fragments. These may also be
seen in cases of pseudogout.
Cholesterol crystals are noted rarely in the
fluid of cases of chronic rheumatoid arthritis. These
crystals are large, rhomboid, have punched-out
corners and are birefringent.
An inexperienced examiner may confuse previously injected corticosteroid ester crystals with
urate or pyrophosphate crystals. The steroid crystals
may be phagocytosed by white cells and apparently
can precipitate a "postinjection flare" of the injected joint. The crystals are usually negatively
birefringent.
Reiter's syndrome synovial fluid has been reported to show large mononuclear cells containing
many vacuoles. Some of these cells appear to contain polymorphonuclear cells. The specificity of this
is unclear.
Table 2 illustrates the complement (C') levels
in various disease entities. It is most helpful, however, to know the normal values and type of complement determination for each laboratory. For
example, if total complement is determined on a
viscous synovial fluid and if a diffusion technique
is used, poor diffusion may occur due to viscosity
and erroneously low level results.
Summary and Conclusions. Examination of synovial fluid is a most helpful test for making a
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McCARTY DJ Jr, HOLLANDER JL: Identification of
urate crystals in gouty synovial fluid. Ann Intern Med
54:452, 1960.

TABLE 2
COMPLEMENT

Serum
Rheumatoid arthritis
Systemic lupus erythematosus
Reiter's
Septic
Crystal disease
Spondylitis & psoriasis

N (rarely l)

Synovial Fluid

N (occ. i)

l
l
ii
t

N
N

Nori
Nori

l
N

definitive diagnosis of one of the various types of
arthritis, especially gout, pseudogout and septic
arthritis. Unfortunately, it is one of the most frequently ignored tests. It should be remembered that
only a few drops of fluid are needed for a "wet drop"
examination for crystals, ragocytes, Gram's stain and
a Wright's stain.
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Surgery in Rheumatoid Arthritis: General Indications
and Philosophic Considerations*
R. S. BRYAN, M. D.
Assistant Professor, Orthopedic Surgery, Mayo Medical School,
University of Minnesota; Consultant, Mayo Clinic, Rochester

An orthopedic surgeon once referred to general surgeons as "residual surgeons"; and in rheumatoid arthritis, orthopedic surgeons might be referred
to as surgeons of the residuum because we are called
only after all of the medical treatments. We would
like to be called earlier because we do have something to offer many patients.
One of the dramatic developments of recent
years in rheumatoid arthritis is the rehabilitation
potential that is realized in total joint replacement.
It is miraculous when a patient who has become
bedfast despite good ·medical management is rendered ambulatory within six weeks by the replacement of two or three lower extremity joints. This
is not possible, however, in every patient; and the
abyss of total disaster and even death lurks behind
every improperly chosen and orchestrated surgical
sequence.
Successful results of surgery in the arthritic
depend as much on a wise choice of patient and
operation as on the skillful performance of the
surgery. The most important consideration in choosing the patient is that' he or she is willing to have
the operation. Operating on unwilling patients often
leads to lawsuits and generally gives rise to discomfort for both patient and surgeon. Willing, however, means not only that the patient is willing to
have surgery, but also that the patient understands
realistically what you are attempting to achieve

* Presented by D r. Bryan at the 45th Annual McGuire
Lecture Series, November 8, 1973, at the Medical College
of Virginia, Richmond.
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and is willing to cooperate fully in order to attain
the desired result.
Motivation is slightly different but is ancillary;
the patient must want to have the operation, not the
relatives. If the relatives push the patient into the
room and say, '"Mother wants to have her knees
operated on," beware. That patient may be perfectly happy to sit in a wheelchair and may be
bitterly resentful after surgery. I mistakenly operated on such a patient, replacing both knee joints
and stretching out contractures of 60 degrees. After
she went home, she took off her braces and allowed
the contractures to recur because "it was too much
bother to wear them." I achieved nothing because
I chose the wrong patient for surgery.
The second facet of motivation is the willingness to continue good medical management. One
of my patients had been taking the "Mexican pill"
and was Cushingoid with destroyed knee joints and
osteoporotic bones. We replaced both knee joints
and reduced her steroid doses to a reasonable li;:vel.
She returned after one year with her knees doing
well but had resumed large doses of steroids because
the other joints limited her activities. We achieved
nothing in that patient since our treatment merely
permitted her to abuse other joints, and we were
unable to make her understand and accept her
disease and its proper management.
There must exist in the properly chosen patient
a need for surgery. If there is a mechanical method
that will suffice by means other than surgery, such
as injection, splinting, or physical therapy, that
method should be chosen.
M CV QUARTERLY 10(1): 18-20, 1974
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Fig. 1-This is a 55-year-old man with rheumatoid arthritis. Note the destruction of bone from the arthritis.

There are also certain basic requirements in
the form of muscles, ligaments, and bone structure
that pertain to each surgical procedure and vary
from joint to joint. In a Walldius total knee arthroplasty, for example, you must have a good quadriceps but do not need ligaments, while in other types
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Fig. 2-Photograph taken at surgery showing the prostheses in place. The high density polyethylene bushing is
seen separating the metal portions of the hinge.

of knee replacement, ligament stability is more
important.
In rheumatoid arthritis, initially, synovitis occurs with little mechanical damage to the joints;
but as the disease progresses, structural changes

Fig. 3 A, B- Th e x-rays show that the axis of the hinge is in line with the anterior surface of the humerus in the correct
position .
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Fig. 4 A, B-These two photographs show the range of motion achieved at three weeks after surgery.

occur that would cause progressive deterioration,
even if the arthritis were miraculously cured. Synovectomy at that late stage accomplishes little. The
difficulty is. in knowing when the mechanical damage
is severe enough to preclude synovectomy. Certainly, when erosion and surface irregularities appear, it is more reasonable to suggest arthroplasty.
When still more destruction has occurred and gross
instability ensues, the choice evolves to a hinged
or unhinged total knee arthroplasty or arthrodesis.
At each stage in the disease-just as in the medical
management, the least lethal medication possible
is used-in surgery, the least lethal operation is
chosen.
One of the bold new experiments involves the
replacement of the elbow joint. Figure 1 shows a
roentgenogram of a rheumatoid elbow with severe

destruction, somewhat resembling the old fascia!
arthroplasties. Figures 2 and 3 show the Coonrad
hinge. This has a polyethylene bushing through
which the cross pin connects the two parts of the
hinge. The stems are cemented to the bone in the
humerus and ulna. The pin rotates and so do the
bushings, giving a wide weight bearing area. Figure
4 shows the patient three weeks after surgery demonstrating his range of motion.
In summary, orthopedic surgery has much to
offer the rheumatoid patient, particularly if the
proper patient is chosen at the proper time. The
advent of the total joint replacements, now in its
infancy, gives renewed hope for the salvage of many
derelicts and for the prevention of the severe disabilities and deformities which were all too frequent
in the past.

Surgical Treatment of the Upper Extremity
in Rheumatoid Arthritis*
CHARLES L. McDOWELL, M. D.
Assistant Clinical Professor, Orthopedic Surgery, Medical College of
Virginia, Health Sciences Division of Virginia Commonwealth
University, Richmond

All surgical procedures designed to preserve
or improve function in the extremities, whether in
rheumatoid arthritis or not, must consider the functional emphasis of the upper extremity as compared
to the lower extremity. The upper extremity has,
as its primary goal, mobility and prehension, whereas
in the lower extremity, stability is the most important goal, mobility the next in order of importance, and prehension the least important. For
example, the feet fulfill a need for stability with
very little requirement for prehension, but the hand
is more an instrument for prehension and there
is less need to consider stability.
I have divided surgery in the upper extremity
of the rheumatoid patient into the surgery of prevention and the surgery of repair-that is, those
procedures designed to prevent the loss of function
and those designed to restore some measure of
function .
Surgery of Prevention. Synovectomy. One might
include synovectomy under the ·surgery of prevention. The question of whether synovectomy is worthwhile as a possible means of controlling the progression of rheumatoid disease in any particular
joint is not appropriate to this discussion. My personal view is that synovectomy alone has not adequately been shown to favorably alter the course
of rheumatoid arthritis in the involved joint, although there is definitely a place for synovectomy

* Presented by Dr. McDowell at the 45th Annual McGuire Lecture Series, November 8, 1973, at the Medical
College of Virginia, Richmond.
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whenever synovial tissue itself interferes with function or when it is causing intractable pain. Further,
synovectomy done in association with certain
anatomic adjustments is an essential element in the
operative procedure. An example of such a situation
is illustrated by the patient who has monarticular
synovitis of a metacarpal phalangeal joint with
severe pain and limitation of motion and who has
not responded to the usual conservative methods
applied over a reasonable period of time. In such
an instance there is a reasonable chance of attaining at least some pain relief if not some improvement in the range of motion of that joint.
Anatomic Adjustments. These are procedures
which are often done in association with synovectomy to prevent further progression of destructive
processes that we know will cause a functional loss
to the patient if some surgical adjustment is not
made. Radial-head excision, along with synovectomy of the elbow joint, may preserve pronation
and supination at the elbow and perhaps even ftexion
and extension at the elbow longer than it would
have been preserved using conservative treatment
alone. The procedure is also helpful in relieving
pain. Radial-head excision is ordinarily not considered as a possibility until there is x-ray evidence
of advanced destructive changes and clin_ical evidence of persistent pain and reduction in the range
of motion.
When the patient has tenosynovitis on the extensor surface of his wrist and hand, there is a
threat of possible destruction of extensor tendons
with consequent severe loss of function. A synovec21
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tomy is in order because the synovial tissue seems
to cause destruction of the tendons by ingrowth into
the substance of the tendon; indirectly, there is
damage by competition with the blood supply and
also by compression underneath the extensor
retinaculum which also interferes with the blood
supply. At the same time that the synovectomy is
done, the extensor retinaculum is removed, so that
if synovitis recurs the tendons will not be exposed
to compression and consequent loss of blood supply.
Usually the retinaculum itself is preserved but rerouted beneath the extensor tendons and sutured
down to the capsule of the wrist joint. This collagen
graft helps to stabilize the wrist joint itself, so that
a tissue which was in a potentially destructive position before surgery is converted to an assistant
which may help to stabilize the wrist joint.
When synovitis in the flexor canal, which contains the long flexor tendons and the median nerve,
increases the pressure within the volar canal, the
patient experiences decreased function of the median
nerve distal to the wrist. There are signs and symptoms of carpal tunnel syndrome. If this condition
is allowed to progress the patient may ultimately
develop a complete nonfunction of the median
nerve and the flexor tendons may rupture; the
mechanism would be the same as that described
for extensor tendons under the extensor retinaculum.
Therefore, a release of the volar carpal ligament
combined with synovectomy will preserve irreplaceable function of the median nerve and probably
prevent rupture of the flexor tendons.
Frequently, synovitis occurs in the flexor tendon sheaths in the finger. When it progresses to the
point where the flexor tendons are unable to glide
through the pulleys, a situation described as "trigger
finger" exists. This painful locking of the flexor
tendons cannot be treated by a simple division of
the pulleys because severe functional loss is a consequence of division of the pulleys. In this instance
a complete synovectomy of the flexor tendons in the
fingers will allow them to become flexible again.
The Surgery of Repair. Repair or Grafting of
Ruptured Tendons. As pointed out earlier, the surgery of repair is indicated when anatomic equipment
has already been destroyed by the rheumatoid
process and some kind of reconstruction or substitution should be considered. Some examples include
the repair or grafting of ruptured tendons. Rupture
of tendons can occur on the extensor surface of the

wrist or in the flexor canal or in the digits as a result
of synovitis as described earlier. Another frequent
cause of tendon rupture is dorsal dislocation of the
head of the ulna with sharp bone edges which
physically abrade the extensor tendons. The repair
is accomplished by placing a tendon graft between
the muscle and the distal stump of the tendon and
by removal of the distal ulna. Other substitution
procedures include such things as tendon transfers
to replace ruptured tendons or to replace a specific
function when there is an imbalance problem caused
by contractures or tendon rupture.
Release of "Stuck" Tendons. Another example
of surgery of, repair is seen in patients who have
ignored the destructive process or were unaware
of the destructive process to the point where the
tendons have stuck together or to surrounding tissues. Consequently, tendon gliding is prevented and
there is no function in the digit. A reconstruction
here requires removal of adhesions to allow the
tendons to glide once again.
Arthrodesis of Small Joints. The small joints
in the hand are exposed to the ravages of rheumatoid arthritis and osteoarthritis follows directly in
its footsteps resulting in severe pain and instability.
Fortunately, some joints do not require motion to
be useful; therefore, an arthrodesis of some small
joints which relieves pain and provides stability can
be a definitive and helpful operation. Arthrodesis
of the thumb metacarpal phalangeal joint and arthrodesis of the wrist are the most commonly performed fusions in patients with rheumatoid arthritis.
Selective Excision of Rheumatoid Nodules. We
are all aware of the fact that rheumatoid nodules
have a high recurrence rate after excision; however,
nodules may appear in areas where they can cause
much pain and interfere with function of a hand
out of proportion to their usually benign nature
and surgical excision is indicated.
Resection Arthroplasty of Small Joints. In the
last thirty years or more, surgeons have been attempting to provide motion and a reduction in pain
in the small joints of the hand by performing an
arthroplasty where arthrodesis was not a reasonable
alternative. We attempted to produce a type of
pseudojoint by removing a portion of the old destroyed joint and substituting some type of soft
tissue, such as fascia or tendon, for articular cartilage. Such soft tissue arthroplasties have helped to
reduce pain in the involved joints and have helped
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to increase the range of motion in the involved
joints; however, the soft tissue arthroplasties have
fallen far short of normal function. The soft tissue
arthroplasties do not hold up over a long period
of time because the interposed soft tissue tends to
disappear with time allowing the bone ends to come
back together and pain is a result.
Replacement Arthroplasty of Small Joints.
Presently, soft tissue arthroplasties are being augmented by the use of a spacer between the two
bone ends to prevent the two bone ends from migrating back together. The spacers which are inserted also have a certain amount of inherent rigidity
which improves the stabilizing characteristics of the
arthroplasty. We are using Silastic® spacers or
prostheses of which there are now three popular
types: Swanson, Niebauer, and Calnan-Nickel (the
Swanson type is illustrated). Experience has shown
that the implant type of arthroplasty can greatly
improve the average range of motion following surgery and can also maintain pain reduction for many
years. Stability is improved over the pure soft tissue
arthroplasty but is not as good as normal. Recurrence of ulnar drift is still a significant problem
in this type of arthroplasty.
Another type of arthroplasty which is moving
us closer to the theoretical optimum of total joint
replacement is the Steffey; it is a metal prosthesis
with two sections. Each section has a stem, which
is inserted into the respective medullary canal, and
a high density polyethylene articulating surface. The
two pieces are snap-fitted together and the stems
are held in place with methylmethacrylate bone
cement. This prosthesis is a direct outgrowth of the
earlier metal prosthesis designed by Brannon and
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Fig. 1-Silastic® finger joint prosthesis of the Swanson
design.

another designed later by Flatt. One of the most
important hopes that we have for this prosthesis is
that it will provide a higher degree of stability. At
the present time, this particular prosthesis is not
widely available.
In closing, I should like to emphasize a point
that Dr. Bryan has made. It is wise for all of us
to appreciate the fact that the surgeon always loses
his battle to rheumatoid arthritis. The best the
surgeon can possibly hope to do is to ameliorate
the symptoms or preserve or sometimes even to reconstruct lost functional parts.

Surgical Care of the Lower Extremity
in Rheumatoid Arthritis*
ROBY C. THOMPSON, JR., M. D.
Professor of Orthopedic Surgery, University of Virginia School of
Medicine, Charlottesville

One of the most important things for the physician to recognize in referring a patient to the
orthopedic surgeon for treatment of rheumatoid
arthritis is the goal of surgical correction. The
primary goal in surgical treatment of diseased joints
in the lower extremity is relief of pain. Some painfree patients have such severe deformities that a
surgical procedure may be undertaken in order to
improve and restore function, acceptjng certain calculated risks; however, to improve function surgically in a pain-free joint requires complete and
full understanding on the part of the patient as well
as the physician.
The Hip Joint. The surgical treatment of rheumatoid disease in the lower extremity has changed
drastically in the last t.en years. Mold arthroplasty,
which was the primary method of treating rheumatoid arthritis of the hip joint until ten years ago,
unfortunately did not provide uniform relief of pain
and good stability in all patients. In the hands of
most surgeons doing mold arthroplasties, the rheumatoid patient got a less satisfactory result than the
patient with degenerative arthritis. The major problem with cup arthroplasty in the patient with rheumatoid arthritis was postoperative stiffness and
residual pain. Figure 1 illustrates the typical complication following this problem, with the cup
settling into the pelvis and the femoral neck shortening under the cup.
The Austin-Moore prosthesis, which was de-

* Presented by Dr. Thompson at the 45th Annual McGuire Lecture Series, November 8, 1973, at the Medical
College of Virginia, Richmond.
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veloped for the treatment of arthritis in the hip joint,
subsequently became widely used for the replacement of the femoral head following neck fractures
in elderly patients. The use of this prosthesis in
rheumatoid disease of the hip was rarely successful.
This prosthesis was designed for stability in bone
on the basis of a press-fit design. It was doomed
to failure in rheumatoid disease of the hip because
of inherent osteoporosis, present in most rheumatoids, which allowed the unyielding metal of the
prosthesis to protrude into the soft bone of the
pelvis and loosen in the soft bone of the femur
where the stem of the prosthesis frequently became
loose in the canal of the femur. My personal experience with femoral head replacement, using the
Austin-Moore or other press-fit design prostheses
in rheumatoid arthritis, has been quite disappointing.
Total hip replacement became popular in England about 15 years ago. One of the earliest prostheses used was made of two metallic components
similar in design to the Ring prosthesis illustrated
in figure 2. Unfortunately, the Ring and other
types of press-fit design prostheses were doomed to
failure in rheumatoid arthritis for the same reasons
that the Austin-Moore prosthesis failed. With our
patients, in whom the Ring prosthesis was inserted
for rheumatoid arthritis, we had good early results.
After a year and a half, however, all but a small
number of these patients had painful hips.
Fortunately, polymethylmethacrylate, a bone
cement, became available for treating arthritic joints.
This surgical cement, used in this country for over
five years, is still distributed out of Great Britain.
MCV QUARTERLY 10(1): 24-33, 1974
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Fig. I-Cup arthroplasty in a rheumatoid hip which failed
because of shortening of femoral neck and protrusion of
the cup into the pelvis.

It has allowed us variability and flexibility for inserting all types of total joint replacements utilized
in the lower extremities today. This cement has many
advantages in a patient with rheumatoid arthritis.
In contrast to the press-fit designs, the cement
backing of a total joint replacement allows a wide
distribution of forces to the bone, and with few exceptions, there has been little settling of the cemented prostheses in rheumatoid arthritis. Charnley
( 1) certainly deserves the credit for establishing
total hip replacement as a method of choice in treating diseased hip joints. Credit goes to him, not only
for the design of the prosthesis which he has popu-

Fig. 2-Ring total hip prosthesis in right hip of rheumatoid
patient. A press-fit design which failed with time in the
osteoporotic rheumatoid.

Fig. 3-The Charnley total hip with a 22 mm femoral
head of stainless steel and a high density polyethylene
acetabulum .

Fig. 4-The Muller total hip with a 32 mm femoral head
of cobalt chrome alloy and a high density polyethylene
acetabulum.
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Fig. SA-Bilateral ankylosed hips in a patient with ankylosing spondylitis. The right hip had previously had a medical
displacement osteotomy while the left hip had sustained a
fracture and subsequently ankylosed.

Fig. 6A-Bilateral ankylosed cups in a 20-year-old juvenile
rheumatoid.

larized, but also for the fundamental work on bone
cement. He did original work on the bone cement
even before he began using total hip replacements
as we know them today.
One prosthesis which is very popular in this
country is the Muller prosthesis ( 2). Materials used
in this prosthesis are similar to those found in the
Chamley prosthesis, with a metallic femoral component and a high density polyethylene acetabular
component. Chamley's prosthesis (Fig. 3) is made
of stainless steel; the Muller prosthesis (Fig. 4)
is made of a cobalt chrome alloy.

Rheumatoid arthritis, in a series of hip replacements at the University of Virginia, has made
up a relatively small proportion of those patients
undergoing total hip replacement. In the first 235
replaced hips, only 35 hips were replaced for rheumatoid arthritis and eight hips for ankylosing spondylitis. In the straightforward rheumatoid arthritic
patient with destruction of the hip and painful motion, the results of total hip replacement, using
cemented prostheses, have been excellent to date.
We have been pleased with the results in patients on
whom we performed this procedure and followed
for three and one-half years without any significant

Fig. SB-Postoperative results following bilateral total hip
replacements.

Fig. 68-Postoperative conversion to Harris replaceabletype total hips. Note ectopic bone formation.

THOMPSON: SURGICAL CARE OF THE LOWER EXTREMITY

27

D.B 10-2-71

Fig. 7C-Postoperative appearance of hips following bilateral total hip replacements.

Fig. ?A-Preoperative condition of patient with ankylosing
spondylitis, fused spine and ankylosed hips (7B).

Fig. 7B.

Fig. 7D-Condition of patient postoperatively following
hip repl acements.
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Fig. 8-Mclntosh plateau prosthesis four years postoperatively with good results.

Fig. 9-Mclntosh prosthesis which failed in rheumatoid
two years postsurgery.

failures intrinsic to the rheumatoid process itself.
In order to show the types of problems that
are suitable for management with total hip replacement, some of the more unusual cases are presented.
A 76-year-old lady with ankylosing spondylitis had
a fused spine, a fused right hip, and an ankylosed
left hip (Fig. SA). She had little pain but was
unable to sit or drive a car. With some trepidation,
we took down her fused hip and used a special type
of prosthesis where she had previously had a displacement osteotomy. Following a successful result
on this hip, the left hip was replaced (Fig. SB);
she is now able to drive a car, sit, and stand. She
does not have normal movement in her hips but
has improved markedly in function.
One of the more difficult problems we face
is the management of the severe juvenile rheumatoid. A 20-year-old boy had bilateral cup arthroplasties four years prior to surgery (Fig. 6A ) . Both
cups were ankylosed and had no motion. We converted his hips to a special type of total hip replacement designed by Dr. William Harris of
Boston (3), using metallic cups which have a replaceable polyethylene liner and a metallic femoral
component. This design concept is used to circumvent the problem of wear in the polyetbylene. At
the present time, all available information suggests
wear rates of the polyethylene to be a maximum
of 1 mm every five years, suggesting that with the
average prosthesis in use today, we can expect a
minimum of 20 years function, assuming linear
wear rates are present. This particular patient developed a complication of ectopic bone formation
around his hip replacements (Fig. 6B), but he is
now able to walk, drive a car, and attend college
regularly, walking without crutches for the first time
in eight years. In addition, prior to surgery, he was
unable to sit; he was only able to lie down or stand.
At the present time, he can sit, stand, and lie down.
Another difficult case which was dramatically
improved by" total hip replacements is a S2-year-old
lady with ankylosing spondylitis, a fused spine, and
hip joints which were ankylosed in 90 degree flexion.
She was able to ambulate only with the use of a
chair for support (Fig. 7 A), and her hip joints were
markedly protruded (Fig. 7B). Following bilateral
total hip replacement, she was able to stand and see
where she was walking, as well as to sit. She did
not have a normal gait because of the fused spine
but was markedly improved (Fig. 7C, D).
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Fig. IO A, B-Postoperative condition of knee in figure 9, converted to a Walldius hinged prosthesis.

Fig. 11-Polycentric knee joint as modified from Gunston
by Bryan and Peterson.

The Knee Joint. As Dr. McDowell points out,
synovectomy is a useful procedure if the knee joint
cartilage itself and the ligaments around the joint
are not destroyed. When there is rampant synovitis,
that is, when there is a single joint persistently involved with effusion and synovitis which has failed
to respond to adequate medical management over
a period of six months, we feel that synovectomy
is the treatment of choice.
In patients with bicompartmental knee disease,
where both medial and lateral tibial' plateaus are
involved as well as femoral condyles, arthroplasty
is the only successful method of treating the destroyed articular surface. Prior to the advent of
total knee replacement, tibial plateau and femoral
condylar prostheses were the only surgical treatments available. In our series of patients, we favored
the tibial plateau prostheses, designed by Mcintosh,
and found that some of these replacements did fairly
well. The patient in figure 8, now four years postsurgery, is essentially pain free and has an acceptable
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Fig. 12 A, B-AP and lateral x-ray of knee with destruction secondary to rheumatoid arthritis.

range of motion and good stability. Many of these
prostheses did not do well and progressed to unstable painful knees. One such patient is a rheumatoid arthritic who lost enough bone following her
Mcintosh arthroplasty to have severe instability and
pain, requiring major joint reconstruction (Fig. 9).
We elected to treat this particular problem by
use of a large hinged prosthesis designed by Walldius ( 4) (Fig. JOA, B). Even though this large
metallic device has limited motion (90 degrees)
and carries a certain incidence of looseness and
infection, it has been in use longer than any other
knee prosthesis on the market and gives acceptable
results in the otherwise unsalvageable knee.
Criteria for Selection of Candidates for Knee
Replacement. Initially, we restricted our patients
for knee replacement to those over 60 years of age.
As we gained experience, we began doing some
younger patients in the rheumatoid arthritis group
but have continued to restrict our indications in
degenerative arthritis to those patients 60 years
of age and older.
There are several currently popular prosthetic
designs available on the market. All of these are
new and little experience has been recorded with

any of these joints. My own preference for a knee
prosthesis is the polycentric knee joint as designed
by Gunston (5) and modified by Bryan and Peterson ( 6) (Fig. 11). I prefer this prosthesis because
it is embedded in a biologic envelope of bone, has
minimal bone cement contact, and has less reliance
on cement-prosthesis contact for stability. In the
knee joint where there is complete loss of joint space
and patellofemoral disease (Fig. 12), we have used
the polycentric arthroplasty, composed of two metallic condyles in the femur and plastic runners in the
tibia (Fig. 13) with good success. This prosthesis
basically allows an increase in space between the
femur and tibia and improves motion as well as
stability in many knee joints.
Another popular arthroplasty in the United
States today is the geometric type (Fig. 14) designed by a group of orthopedic surgeons from four
different hospitals (7). This two-piece prosthesis
requires resection of more bone than the polycentric
arthroplasty, and I have reserved this prosthesis for
patients with severe osteoporosis and marked joint
destruction with more than 30 degrees of varus or
valgus instability. This particular knee joint (Fig.
15) had such severe osteoporosis, the surgeon's
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Fig. 13 A, B-AP and lateral x-ray of knee in figure 12 following polycentric arthroplasty.

Fig. 14-Geometric knee joint.

thumb could easily be pushed through the femoral
condyles. A polycentric type of arthroplasty is extremely difficult to perform in bone as soft as the
bone in this particular patient, and the geometric
design has allowed us to replace joints of this type
providing excellent stability and good motion. The
average hospital stay for knee replacements at the
University of Virginia is 26 days for unilateral
surgery in contrast to an average of 21 days for
unilateral hip replacement.
Complications. We have had no cases of phlebitis in our total knee replacements, a fact which
may be due to our prophylactic regimen. We use
dextran-40 for our total knee replacements, infusing
200 ml of low molecular weight dextran prior to
inflation of the tourniquet. The remaining 300 cc
are infused after the tourniquet is released. The
patients receive 500 cc of dextran-40 daily for three
days and then every third day until discharge from
the hospital. We have had two cases of hepatitis
in our knee replacements-one patient, presumably
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Fig. 15 A, B-Pre- and postoperative x-rays of knee with severe osteoporosis where geometric knee joint was used for
arthroplasty.

from a transfusion, and the other, anesthesia-related.
We have had no wound infections to date in our
knee replacements, which total 35, with a minimum
of six months follow-up.
Ankle and Foot. The ankle is a difficult joint to
treat in rheumatoid arthritis, primarily because it is
rare to have ankle disease alone without subtalar
joint disease. Ankle fusion bas been successful in
several patients I have treated, when the ankle
has been involved as an isolated joint. The goal of
surgery in this particular problem must be pain
relief, as function is rarely improved except as related to relief of pain.
One of the more successful surgical procedures
in the low~f extremity has been the treatment of
forefoot disease in the rheumatoid patient. In those
patients with severe hallux valgus and prominent

metatarsal heads on the plantar surface of the foot,
resecting the metatarsophalangeal joints has given
good pain relief in our hands. Again, function can
only be improved on the basis of pain relief.
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Diagnostic Concordance of Serological Tests
for Antiglobulin Antibodies* **
MARION WALLER, PH. D.
Professor of Medicine, Division of Connective Tissue Diseases,
Medical College of Virginia, Health Sciences Division of Virginia
Commonwealth University, Richmond

Rheumatoid factors are present in a variety of
disease states and in normal persons, usually in low
titer. High titers of .rheumatoid factors are almost
exclusively associated with rheumatoid arthritis.
A second group of antiglobulin antibodies,
called serum agglutinators, distinct from rheumatoid
factors, are anti-Fab IgG antibodies presumably
present in the sera of all mammals. High titers of
these antibodies are not diagnostic for a specific
disease but are closely associated with suppurative
infection which is usually due to gram-positive
organisms.
Tests for determining the titers of the serum
agglutinators are used as diagnostic aids for hidden
abscesses. In suppurative infection, and especially
in gram-positive septicemia, titers are very high.
Elevated titers have aided in differentiating osteomyelitic abscesses from des tructive tumor lesions
of the bone. The titers of the serum agglutinators
will fall when the suppurative lesions resolve; thus,
falling titers of these antibodies help in evaluating
the resolution of large lesions. In addition, the failure of the patient to respond with a rise in titer
in the face of significant or multiple abscesses is
usually a warning that the patient is not immuno':' Presented by Dr. Waller at the 45th Annual McGuire
Lecture Series, November 9, 1973, at the Medical College
of Virginia, Richmond.
** This is publication No. 65 from the Charles W.
Thomas Arthritis Fund, Medical College of Virginia, and
was supported in part by the Herbert L. Earnest Arthritis
Fund for research.
Reprint requests to Dr. Marion Waller, Department of
Medicine, Medical College of Virginia, Richmond, Virginia 23298.
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logically competent, such as patients with thymoma,
lymphoma or myeloma. Figure 1 demonstrates the
method used for studying both of these antiglobulin
antibodies.
Rh-positive erythrocytes coated with the incomplete anti-Rh antibody, Ripley, are used to
demonstrate the rheumatoid factors. These antiRh antibodies, hydrolyzed with various enzymes,
are used to demonstrate the different serum agglutinators. Erythrocytes coated with a mixture of
intact antibodies and the Fab fragments of antibodies will permit the demonstration of both antibodies.
This prospective study of 1,320 persons, whose
sera were examined for the presence of both rheumatoid factors and serum agglutinators, was undertaken to evaluate and compare the effectiveness of
the tests for these two distinct antiglobulin antibodies as diagnostic aids in rheumatoid arthritis and
suppurative infection, respectively. Three groups of
patients were tested:
Group I (hospital patients )-Serum specimens
from 181 hospital patients were sent to our laboratory primarily to be tested for the presence of
serum agglutinators.
Group 2 (ambulatory patients)-Serum specimens from 926 patients attending the connective
tissue (rheumatology.) clinics were sent to our
laboratory to be tested for the presence of rheumatoid factors.
Group 3 ("normal" persons attending the city
venereal disease clinic)-Serum specimens were
obtained from 213 persons attending the venereal
disease clinic. They were primarily young adults,
MCV QUARTERLY 10(1): 34-37, 1974

WALLER: SEROLOGICAL TESTS FOR ANTIGLOBULIN ANTIBODIES

0

~

ANTI-Rh
<::.,.
ANTIBODY ~

%

Rh POSITIVE
ERYTHROCYTE

0

c-=1

*

35

TABLE 1

RHEUMATOID
FACTOR

0
I

PROTEOLYTIC
ENZYME

~
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\

0,

INCIDENCE OF POSITIVE TESTS FOR ANTIGLOBULIN ANTIBODIES*
Test for Rheumatoid Test for Serum
Factors
Agglutinators
-------

Study Total No.
Group Patients

2
3
Totals

No.
Positive

Percent
Postive

13

No.
Percent
Positive Positive

181
926
213

148
3

7.1
16.0
1.4

27
5
4

14.9
0.5
1.9

1,320

164

12.4

36

2.7

Norn. Group 1 = hospital patients. Group 2 = patients
attending the rheumatology clinic. Group 3 = patients
attending the venereal disease clinic.

* Reprinted by permission from Am J Med 54: 731-734,
1973.

TABLE 2

Fig. 1.

TESTS FOR SERUM AGGLUTINATORS JN 181 HOSPITAL PATIENTS
(GROUP 1) WITH A VARIETY OF DISEASES*
Patients (no.)

some with and some without complaints of urethral
or vaginal discharge. Neither antiglobulin test was
ordered; these were used as a control group.
For this study, only titers of 160 or above were
considered as positive tests. Table 1 shows the results of the tests for rheumatoid factors and serum
agglutinators in 1,320 patients. The incidence of
positive tests for serum agglutinators was highest
in the hospitalized patients (group 1), whereas the
incidence of positive tests for rheumatoid factors
was highest, understandably, in the patients attending the rheumatology clinic (group 2). In the patients attending the venereal disease clinic (group
3), the incidence for both types of antiglobulin antibodies was only 1-2%.
Table 2 shows the variety of diseases among
the 181 hospital patients. The association between
positive tests for serum agglutinators and suppurative infection is apparent. In patients with pneumonia, suppuration is variable; in addition, there
is natural drainage, and the patients receive early
therapy. Thus positive tests are not usual. The
incidence of positive tests in patients with localized
infections depends upon the severity of the lesion.
In neither malignancy nor metabolic disease are

Infection
Gram-negative septicemia
Pyelonephritis
Pneumonia
Granulomatous infection
Subacute bacterial endocarditis
Large abscesses (empyema, osteomyelitis)
Infections associated with immunologic
deficiency (lymphoma, thymoma ,
myeloma, transplantation)
Localized infection (gonorrhea,
pyoderma tonsillitis, infectious
arthritis , wound infection , decubitus
ulcers)
Malignancy
Connective tissue diseases (rheumatoid
arthritis, lupus, gout)
Undiagnosed (fever of undetermined
origin)
Metabolic disease (diabetes, nephrosis,
toxic drugs, muscular dystrophy,
alcoholism, cardiovascular disease)
Totals

Total
2
6
11
8
3
19
5

Positive
Test

1
2
3
12

25

4

14
19

2

15
54

181

27

* Reprinted by permission from Am J Med 54: 731-734,
1973.
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these antibodies present in high titer. The exception
in this instance was a patient with chronic alcoholic
cirrhosis, hematuria and a hemolytic anemia of
unknown etiology. Among the patients with connective tissue disease were a two-and-a-half-year-old
child with lupus erythematosus and a young boy
with juvenile rheumatoid arthritis; both had high
titers of serum agglutinators. In neither of these
diseases are the tests usually positive. It was the
first hospital admission for both children, however,
and the possibility that titers may be high in early
and explosive disease and then decline in the
chronic state cannot be ruled out. Neither child
had a positive test for rheumatoid factor or for
lupus erythematosus.
Table 3 shows the correlation (or lack of it)
between the positive test and the disease for which
the test was ordered. The serum agglutinator test
was ordered for the hospitalized patients (group 1);
the rheumatoid factor test was ordered for the
patients attending the rheumatology clinic (group
2); and neither test was ordered for the patients
attending the venereal disease clinic (group 3) . ·In
13 of the 181 hospitalized patients, the tests for
rheumatoid factors were positive but only six of
the 13 had rheumatoid arthritis. Thus, the correlation between positive test and disease state was
only 46.2%. Among the same patients, however,
21 of 27 with positive tests for serum agglutinators
had suppurative infection.
In the patients attending the rheumatology
clinic (group 2) , there was a very high correlation

TABLE
PRESENCE

OF

RHEUMATOID

3

ARTHRITIS

OR

SUPPURATIVE

INFECTION IN PATIENTS WITH POSITIVE TESTS FOR RHEUMATOID
FACTORS OR SERUM AGGLUTINATORS*

Rheumatoid
Factor
Study Test
Group Positive
1
2
3
Totals

Serum
RheuAgglu- Suppuramatoid Percent tinator
tive
Percent
Arthritis Correla- Test Infection CorrelaPresent
tion Positive Prese.n t
tion

13
148
3

6
145
0

164

151

46 . 2
98.0
None
. 92.0

27
5
4

21
0

77.7
None
25 .0

36

23

63.0

• Reprinted by permission from Am J Med 54: 731-734,
1973.

TABLE

4

FALSE-POSITIVE TESTS FOR ANTIGLOBULIN ANTIBODIES*

Rheumatoid Factor
Test

Serum Agglutinator
Test

No. Positive
No. Positive
Total
Without Percent
Without Percent
Study No. Rheumatoid False- Suppurative FalseGroup Patients Arthritis Positive Infection Positive
2
3
Totals

181
926
213

7
3
3

3.8
0.3
1.4

6
5
3

3.3
0.5
1.4

1,320

13

0.9

14

1.0

* Reprinted by permission from Am J Med 54 : 731-734,
1973.

between the positive test for rheumatoid factor and
the presence of rheumatoid arthritis. Of these 926
patients, five had a positive test for serum agglutinators (0.5 % ) , but norte had a suppurative infection.
Of the 213 patients attending the venereal
disease clinic (group 3), three had a positive test
for rheumatoid factor (1.4 % ) . Only one of these
three had gonorrhea. None had rheumatoid arthritis.
Of these 213 patients, four had a positive test for
serum agglutinators ( 1.9%). Only one had gonococcal urethritis.
If the results of tests for rheumatoid factors
and serum agglutinators, as standardized in this
study, are evaluated for correlation of the test with
specific disease, the percentages of false-positive tests
among the hospitalized patients (group 1) are
3.8% and 3.3%, respectively; among the patients
attending the rheumatology clinic (group 2), 0.3%
and 0.5%, respectively; and among patients attending the venereal disease clinic (group 3), 1.4%
and 1.4%, respectively (T:ible 4). These percentages of false-positive tests are much higher when
titers lower than those used as the standard in this
study are accepted as positive tests.
Comments. The requirements for a positive test
for rheumatoid factors in this study are more stringent than those used in other studies. Even so, only
46.2% of group 1, with rheumatoid factor titers
of 160 or above by the sensitized human cell test,
had rheumatoid arthritis. The sensitized sheep cell
tests were positive for rheumatoid factor in three
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of the hospitalized patients in the absence of rheumatoid arthritis; the diagnoses in these were
Wegener's granuloma, chronic heart failure, and
sarcoidosis. Thus, it is necessary to conclude that
among very sick patients, positive tests for rheumatoid factors only correlate with rheumatoid arthritis
about 50% of the time. In patients in whom there
is a high degree of suspicion of the disease, however,
the correlation is about 98 % . It is also obvious
that among ambulatory patients attending a clinic
for a completely unrelated disease, positive tests
for rheumatoid factors are not apt to correlate with
rheumatoid arthritis.
Among the 181 hospitalized patients, 27
( 15 % ) had elevated titers of serum agglutinators,
which reflects the interest in infection in this group
of patients, since the test ordered was for the serum
agglutinators. Positive tests -for serum agglutinators
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are unusual in nonhospitalized patients and as a rule,
those who do have positive tests do not have severe
suppurative infection. In many instances, however,
these tests might be helpful in differentiating a hidden abscess from a malignancy. Sometimes, a wellwalled-off abscess will cause only modest elevations
in the titers of the serum agglutinators, whereas,
when the abscess is pierced, its inevitable discharge
will stimulate the serum agglutinators and the titers
will rise. As resolution of the lesion occurs, the
titers will fall.
This study lends credence to the postulate that
rheumatoid factors are humoral heterophil antibodies that may be stimulated by a variety of immunologic events. As stated, the correlation of positive tests for these antibodies with rheumatoid
arthritis is only about 50% in very sick hospitalized
patients.

SHll' s Disease in Adults* **
WILLIAM M. EDWARDS, M. D. AND STEPHEN R. KOLLER, M. D.
Fellows in Rheumatology, Division of Connective Tissue Diseases,
Medical College of Virginia, Health Sciences Division of Virginia
Commonwealth University, Richmond

MICHAEL J. MILLER, M. D.
Senior Assistant Resident in Medicine, Department of Medicine,
Medical College of Virginia, Health Sciences Division of Virginia
Commonwealth University, Richmond

In 1897, Dr. George F. Still described 22
children with a form of chronic joint disease which
differed from rheumatic fever ( 1). Twelve of these
children had a syndrome characterized by glandular
and splenic enlargement which, with a characteristic
fever pattern, rash, and arthritis, has become known
as Still's disease (2). Subsequent investigators have
described patients over age 16 presenting with similar signs and symptoms suggesting that this syndrome is not specific for children (3, 4, 5, 6). We
recently studied a patient in whom the diagnosis of
adult onset Still's disease was made.
Case. J . 0 . is a 44-year-old male who was referred to the Medical College of Virginia Hospitals (MCVH) on May 22, 1973 for evaluation
of fever of 12 weeks duration. In addition to the
fever, he had a 25 pound weight loss over a four
month period, shaking chills, drenching night sweats,
and progressive weakness and anorexia. Two months
prior to admission, pain developed in his right knee
and soon progressed to involve the right great toe,
both wrists, and fingers of both hands. Aspirin at
variable doses, prescribed by his private physician,

* Presented by Drs. Edwards, Koller, and Miller at the
45th Annual McGuire Lecture Series, November 9, 1973,
at the Medical College of Virginia, Richmond.
* * This is publication No. 68 from the Charles W.
Thomas Arthritis Fund.
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was not helpful. He had been admitted to another
hospital on May 7, 1973, where he underwent extensive laboratory and radiological evaluation, but
the cause of his symptoms was not ascertained and
he was transferred to MCVH for furth~r diagnostic
investigation.
Past medical history revealed that 12 years
earlier, he had been seen in another hospital for
arthritis involving his right wrist which quickly
resolved. He acknowledged mild morning stiffness
in his fingers for several years prior to his present
illness but denied swelling, heat, redness, or decreased function in any joint. Adult onset diabetes
mellitus had been diagnosed one year earlier and
had been treated with tolbutamide, 500 mg daily.
Family history was noncontributory. The patient lives in a rural setting and is employed as a
maintenance worker in a local seat belt factory.
He denied the use of cigarettes or alcohol.
Physical examination on admission revealed
a T 102°F (39°C), P 92/ min., BP 110/ 58. He
was in no distress. Pertinent findings included a
congenital terminal nystagmus on lateral gaze and
numerous nontender, firm, small, freely movable
lymph nodes in the anterior cervical region, right
axilla, left inguinal, and left epitrochlear areas. The
lungs and heart were normal. The liver measured
10 cm and was palpable 2 cm below the right costal
MCV QUARTERLY 10(1): 38-42, 1974
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inargin on deep inspiratiort. The spleen was not
palpable. The right knee contained a moderate
effusion but was neither warm nor tender. Both
wrists were tender and evoked pain on passive
range of motion. The remainder of the physical
examination was normal.
Representative hematological values were:
hemoglobin 10 gm%, WBC 12,000/ mm 3 with 75%
PMN's, 20% lymphocytes, 5% mononuclear cells,
and an ESR 66 mm/ hr. (Wintrobe) . Representative
chemistries included an albumin 3.2 gm% , total
bilirubin 0.3 mg%, alkaline phosphatase 125 mU /
ml, lactic dehydrogenase (LDH) 325 mU/ ml
(LDH-4 and 5 isozymes elevated), and serum
glutamic oxaloacetic transaminase (SGOT) 70 mU/
ml. The following tests were either normal or negative : urinalysis, blood cultures, latex flocculation,
antinuclear antibody test (ANA), LE cell preparations, HBAg (by CEP), heterophil, T,i, T4, sickle
cell preparation, serologic test for syphilis (STS),
blood urea nitrogen (BUN) , creatinine, calcium,
phosphorus, uric acid, amylase, antistreptolysin-0
(ASO) titer, febrile agglutinins for typhoid, brucella,
proteus, tularemia, and ioxoplasmosis. Several blood
sugar determinations were above the normal range,
the highest being 180 mg%. Intermediate and second
strength PPD's were negative and a mumps antigen
elicited 15 mm of induration. Examination of the
cerebrospinal fluid and bone marrow was not helpful.
Routine and tuberculosis (Tbc) cultures from
synovial fluid, urine, sputum, bone marrow, spinal
fluid, and liver were negative. Upper gastrointestinal
series (UGI), barium enema, IVP, hand, wrist, and
chest x-ray studies were normal. Cervical spine films
showed only mild degenerative arthritis. A liver
scan was normal. Serum protein electrophoresis
showed increased a-1 and a-2 globulins only. Analysis of synovial fluid from his right knee revealed
a WBC 1,144/ mm 3 with 30% polymorphonuclear
leukocytes (PMN's) , 31 % lymphocytes, and 39 %
mononuclear cells.
A biopsy of subcutaneous tissue from the patient's left forearm showed a granulomatous reaction with moderate vasculitis and lipid-filled
macrophages. He underwent an exploratory laparotomy with celiac lymph node and liver biopsies.
Histopathological interpretation of the liver was reactive hepatitis compatible with a number of systemic diseases and the lymph node showed chronic
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lymphadenitis with lipoid granuloma. A congo red
stain for amyloid was negative.
The patient was discharged June 25, 1973 on
3.6 grams of salicylates per day in divided doses.
Because of his mild glucose intolerance, it had not
been felt necessary to supplement his diabetic diet
with any drug therapy. He was readmitted July 15,
1973 because of persistent quotidian fever, pain in
his proximal interphalangeal joints, and morning
stiffness. In addition, he now complained of pruritus
over his entire body associated with temperature
elevations, although no rash was present. He had
g:;iined five pounds since the first admission. At this
time he was found to have pain over the medial
aspect of his right ankle. X-rays of his hands and
wrists now revealed patchy osteoporosis and cystic
lucencies involving the radial styloid and proximal
row of carpal bones (Fig. 1) . He was discharged
July 25, 1973 on salicylates and Benadryl® with
a diagnosis of seronegative rheumatoid arthritis.
Outpatient visits over the next two months
documented continued quotidian fever (Fig. 2) and
progressive arthritis, and on September 27, 1973,
he was readmitted to the hospital. A maculopapular
rash, lasting hours, mostly on his arms, now accompanied the temperature elevations. A synovial
biopsy of the right knee was performed showing
nonspecific chronic synovitis (Fig. 3). Serologic
testing continued to be negative. A diagnosis of adult
onset Still's disease was made and, in addition to
salicylates, gold therapy was instituted.
Over the ensuing months, the patient has felt
better, has gained 17 pounds, and has experienced
general improvement of his joint symptoms. The
general malaise, anorexia, night sweats, chills, and
persistent quotidian fever have abated. He still, however, has an occasional temperature elevation with
an associated fleeting rash.
Discussion. Despite the increasing sophistication of the practice of medicine and its effect on
our diagnostic capabilities, certain patients continue
to baffle the most astute clinicians with fever of
undetermined origin (FUO). Many of these patients
turn out to have neither infectious nor neoplastic
disorders but, rather, connective tissue diseases, such
as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), or even acute rheumatic fever
(ARF) (7, 8). Still's disease, which is commonly
included among the causes of FUO's in children,
has been shown to persist or recur in adulthood
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Fig. 1-The hand and wrist on the left are normal in May 1973. A subsequent x-ray of the same joints in September
1973, illustrates the cystic lucencies and osteoporosis.

(5, 9). In recent years, however, attention has
focused on a syndrome indistinguishable from childhood Still's disease occurring de novo in adults (3,
4, 5, 6).
Although there is no pathognomonic finding
in adult onset Still's disease, certain features may
be diagnostically useful. A quotidian fever pattern
is the rule rather than the exception. This quotidian
pattern may, however, be preceded or succeeded
by a remittent or even double quotidian pattern. It
has been pointed out, also, that the fever may be
present for weeks or for months before arthritis
develops (2, 5). Often, in association with the
temperature elevations, a macular or maculopapular
rash is noted particularly in areas of pressure or
friction. This migratory, evanescent eruption may
recur for months in adult onset Still's disease in
contrast to that of acute rheumatic fever which

rarely persists longer than two weeks (2, 3, 5). Of
historical interest concerning the rash of RA and
juvenile rheumatoid arthritis (JRA), in 1956 Isdale
and Bywaters (10) reported four adults who developed a rash in association with other systemic
manifestations indistinguishable from Still's disease.
It was not until 1971, however, that these same
women, along with ten others, were the clinical
material for Bywaters' original description of adult
onset Still's disease (3). Many biopsies of the rash
in adult onset Still's disease have been described,
yet they all show nonspecific histology, that being
a mild subepithelial and perivascular polymorphonuclear leukocyte infiltrate (3, 4, 5, 10).
Lymphadenopathy and splenomegaly correspond significantly with the high fever, rash, and
leukocytosis in childhood Still's disease ( 11). While
no mention was made of lymphadenopathy, By-
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waters ( 3) did note splenomegaly in two of his
patients with adult onset Still's disease, whereas
six out of ten of those cases reported from the
National Institutes of Health (NIH) had splenomegaly and seven had lymphadenopathy. As in our
patient, the liver may be involved with an inflammatory infiltrate which may recur with relapses of
the disease and return to normal after recovery ( 5) .
It has been said that chronic erosive arthritis
involving cervical spine, sacroiliac, temporomandibular, or peripheral joints may occur in a third or
more of children with acute onset JRA ( 11, 12, 13).
Radiographic studies of these areas have not been
helpful in the adult form of JRA. Although erosive
arthritis including cervical spine involvement has
been documented in seven of 26 cases, it is usually
not severe or widespread (3, 4, 5). On the other
hand, arthralgias or nonerosive arthritis may be very
common but transient (3, 4, 5). The histology of
the synovium may vary in severity from a very mild
inflammatory reaction as reported by Bywaters (3)
to a very intense inflammatory response as reported
by Fabricant et al. ( 4).
In addition to the more characteristic features
of adult onset Still's disease, namely fever, rash,
lymphadenopathy, and arthralgias or nonerosive
arthritis, one may encounter less specific symptoms.
Myalgias, particularly of the lumbar, cervical, or
thigh regions, sore throat, alopecia, pericarditis
pneumonitis, and pleurisy, with or without a pleural
effusion, have been described. Abdominal pain may
occur which possibly reflects mesenteric lymphadenitis ( 5). In contrast to JRA, especially the oligo-
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Fig. 2-0ral temperatures recorded by the patient show
the characteristic quotidi an fever pattern of adult onset
Still's disease.
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Fig. 3-Light microscopy of synovium obtained by needle
biopsy shows synovial lining cell proliferation and round
cell infiltration with edema and endothelial proliferation of
the sublining tissue.

articular form, iridocyclitis is notably absent in
adult onset Still's disease. Likewise, rheumatoid
nodules are not found.
As in many other connective tissue disorders,
laboratory confirmation of adult onset Still's disease
is not possible. Characteristically, rheumatoid factor
is not found in the sera of these patients. Probably the most helpful finding is a neutrophilic leukocytosis. Of 12 patients with adult onset Still's disease, ten had WBC's greater than l 8,000/ mm 3 with
over 70% neutrophils. Similarly, the ESR is elevated and often parallels disease activity (3, 4, 5).
In only two patients with adult onset Still's disease
has synovianalysis been reported, one showing a
white opaque fluid with 69,000 WBC/ mm 3 and
the other, a yellow turbid fluid with 14,000 WBC/
mm 3 • In both aspirates, over 90% of the cells were
polymorphonuclear leukocytes ( 4) .
Because of the therapeutic and prognostic implications, physicians should be especially aware
of a syndrome occurring in an adult, which is indistinguishable from Still's disease. Salicylates in
doses which maintain a serum level of 25-30 mg%
may induce symptomatic relief in many patients
with adult onset Still's disease. Others do not respond as favorably and may require additional
therapy. Of the ten patients with adult onset Still's
disease comprising the NIH study, four responded
to high-dose aspirin or indomethacin therapy ( 5) .
Chloroquine, used in conjunction with aspirin, reportedly maintained a normal ESR and good func-
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tional state in one of Bywaters' patients, although
erosive carpal bones and ankylosis of C 2-3 were
present (3) . Ultimately, however, the majority of
patients with adult onset Still's disease have been
treated with prednisone. Alternate-day therapy is
preferred if one must resort to steroids; however,
it has been noted by Bujak et al. (5) that symptoms
recur on the off day unless the steroids are accompanied by very high salicylate doses. Even steroid
therapy may not fully suppress the activity of adult
onset Still's disease. One patient who subsequently
had a remission on gold therapy was reported by
Fabricant et al. ( 4) to have experienced active
symptoms despite 30 mg of prednisone daily. The
only other mention of gold therapy in adult onset
Still's disease has been by Bywaters in his original
series, where he commented on two patients who
improved while taking gold. In one patient, the gold
therapy was instituted while steroids were being withdrawn and in the other patient, it was given in
addition to aspirin and prednisone (3). Thus, our
patient represents the only report to date of a patient with adult onset Still's disease responding to
gold therapy without previous or concomitant corticosteroid therapy.
Conclusion. A patient with adult onset Still's
disease and a review of the literature pertinent to
this syndrome is presented. Several features should
be emphasized: 1) Adult onset Still's disease should
be considered in those patients with FUO who have
an evanescent rash, leukocytosis, arthritis, or arthralgias and Iymphadenopathy. 2) The prognosis of
adult onset Still's disease is good with few patients,
so far reported , developing chronic erosive arthritis.
3) The majority of patients with adult onset Still's
disease will respond to salicylates, although some
will require corticosteroids or gold therapy.
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Genetic-Metabolic News
One of the primary aims of the genetic counselor is the reduction in the number of children
born with either lethal disorders or severe CNS
dysfunction (eg. mongolism and midline neural defects). Generally, this goal is accomplished in one
of four major ways:
1) Where a child's disorder is known to be
inherited in a Mendelian fashion, by clearly
stating the recurrence risk of 1 : 2 or 1 : 4,
which is often a deterrent to a parent pair
to plan further pregnancies;
2) By counseling based on empirically established recurrence risk statistics;
3) Where the risk is high, by determining the
status of the fetus at 14-16 weeks by
aspiration and study of amniotic fluid (amniocentesis,)-when the mother is over
age 40, or has had a previous child with
mongolism, a sex-linked disorder, or one of
so~ fifty metabolic disorders which may
be diagnosed by amniotic fluid study, the
pregnancy can be terminated before twenty
weeks gestation if one of the disorders is
detected;
4) By ascertainment of parent pairs where
both are carriers of an autosomal recessive
disorder before birth of an involved child
so that parents may be advised of the high
risk of occurrence of this disorder in their
offspring and also be advised of the availability or nonavailability of intrauterine
diagnosis by amniocentesis.
At present, two carrier detection programs (for
sickle cell anemia and Tay-Sachs disease) have been
developed because the following necessary criteria
have been met:
1) The carrier test is rapid, accurate, and inexpensive within a defined population;
2) The frequency of the carrier state is high
enough within a defined population to justify the
cost of testing;
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3) The disorder is a serious health hazard for
which there is no definitive cure.
One other disorder, cystic fibrosis (rare in the
Black race) meets criteria 2 and 3 but unfortunately,
not 1. As soon as an effective carrier test for this
disease is developed, however, it will be offered
to whites just as today, blacks have available sickle
cell testing and Jews, a Tay-Sachs screening test.
The major purpose of this article is to briefly
summarize the concept of a Tay-Sachs carrier detection program and to share our experiences in
Virginia. This disease, first described by Drs. Tay
and Sachs in the 1880's, was classified for over
sixty years as a "degenerative disorder" of the
central nervous system (CNS).
Approximately five years ago, however, it was
shown that the disorder is due to the deficient
activity of an enzyme, hexosaminidase A, which
catabolizes a normally occurring ganglioside. The
accumulation of this sphingolipid causes progressive
CNS deterioration in an infant who previously developed normally for the first six-to-nine months
of life. Death by the age of four or five is inevitable
since no cure is available or imminent.
Over the past few years, an accurate procedure
for the quantitation of hexosaminidase A (hex A)
activity in serum has been developed whioh identifies
the carriers of this autosomal recessive disorder.
Because the Tay-Sachs disease occurs one hundred
times as frequently in Ashkenazi Jews (those Jews
of Eastern European and Russian ancestry who
represent 90% of the United States Jews) as compared to Gentiles and Sephardic Jews, it has become
feasible and advisable to use this test to screen this
population for the carrier state. Identification of
the carrier is important for the following reasons:
1) It alerts relatives of carriers (through appropriate genetic counseling) of their very
high- risk for also being a carrier;
2) It allows identification of couples in the
childbearing age who may both have the
abnormal gene and are therefore at a 1 : 4
43
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risk for having a Tay-Sachs infant. If both
members of a parent pair are carriers,
three alternatives exist:
a) limitation of family size;
b) therapeutic termination of an involved fetus
diagnosed by amniocentesis in the 4th
month of pregnancy;
c) artificial insemination from a male known
not to be a Tay-Sachs carrier-this approach would only be suggested where
amniocentesis or termination of pregnancy
are not acceptable to the parents.
Over the past twenty months, the Departments
of Pediatrics and Pathology at MCV, in cooperation
with the Virginia State Health Department and
concerned local physicians and volunteers, have
organized intensive educational campaigns to outline the rationale of Tay-Sachs carrier testing. These
efforts in Richmond, Roanoke, Norfolk-Virginia
Beach, Hampton-Newport News, and Fredericksburg, have yielded a voluntary turnout of over 3600
adult Jews at designated testing dates in community
centers.
Complete analysis of over 2000 specimens
has thus far disclosed a carrier incidence of 1: 30.
This figure is in close agreement with the 1 : 28
figure found by the first and largest "outreach"
Tay-Sachs screening program-that developed by
Dr. Michael Kaback of the Johns Hopkins University Medical Center for the Baltimore-Washington area. Approximately a dozen other large
cities have launched similar programs, but none
has surpassed the Virginia experience in providing
this testing to so many people over so large an area.
Of equal importance to education and testing
in such a detection program is the availability of
adequate counseling for the carrier. Professional
genetic counselors have provided this service for
every Tay-Sachs carrier in Virginia, including advice
concerning the importance and method of testing
at-risk relatives.
The ultimate national goal of such a carrier
detection program is to avert the birth of TaySachs children. This could be done most efficiently
by testing only married Jewish couples in the
child-bearing age prior to their planning any children. Because lack of funds and the complexity of
the enzyme measurement presently prohibit the
wide spread availability of the test, however, this
is not feasible in most areas of the country. Logic
dictates, therefore, that the best alternative is first

to identify which families (in cities where the test
is available) carry the gene abnormality and then
to urge testing for high-risk relatives residing in
smaller cities where screening is not available. The
MCV Tay-Sachs Screening Program has received
frozen serum from as distant a city as Niagara
Falls, New York, where the relative of a Richmond
carrier resided.
For further information regarding the MCV
Tay-Sachs Screening Program, contact either Dr.
Peter Mamunes or Dr. Seymour Bakerman by
writing to Box 187, Medical College of Virginia,
Richmond 23298, or by telephoning 804-770-3033.
Sickle cell disease differs from Tay-Sachs disease in many ways. From the standpoint of carrier
detection programs, however, the most important
differences are that:
1) The test is much simpler and blood specimens can be mailed into a central laboratory;
2) The carrier rate is considerably higherapproximately 1: 12;
3) No prenatal test is available when both
parents are known carriers.
For these reasons, a greater effort of education and
testing at an earlier age are indicated.
Much of the screening for sickle cell trait in
in the state of Virginia is accomplished by the
Virginia Sickle Cell Anemia Awareness Program
(VaSCAP) of the Medical College of Virginia, and
the sickle cell program of the State Health Department. The purposes of these programs are to educate the public, to provide a screening for young
people who wish to know whether they carry the
recessive trait for sickling, and to provide counseling
for those who have been tested.
The VaSCAP program at the Medical College
of Virginia tests young people in the child-bearing
age, as well as premarital blood samples when
the test is desired. A total of 11,000 specimens
per year have been screened, many of them from
the Richmond metropolitan area. The laboratory
of the Stat0 Health Department has a capacity for
up to 40,000 tests a year and collects samples from
all over the state from individuals of any age.
The VaSCAP program at MCV also provides
educational services for the school systems in greater
Richmond and other outlying areas, as well as educational programs for organizations and health
clinics where it is requested. Screening programs
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are provided for public schools and colleges in the
area, and counseling programs are offered for individuals tested in the program. In addition, the
VaSCAP program has provided a series of seminars
for public health nurses throughout the state to
teach a larger number of individuals the principles
of counseling for sickle cell trait.
The offices of the Virginia Sickle Cell Anemia
Awareness Program are at 1008 East Clay Street,
Richmond, Virginia 23298, and the program is
supervised by Mrs. Florence Cooper. The telephone
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number is 770-7797. The program of the State
Health Department is directed by Dr. Patricia Hunt,
Director, Bureau of Child Health, with offices in
the Madison Building in Richmond.
Carrier detection programs, such as those above
described, have proven that the public will voluntarily present themselves for testing if there is appropriate precedent education and follow-up counseling. Every physician should acquaint himself with
these recently available services and join the effort
to reduce the incidence of these dreadful disorders.

A Message to Our Readers:
The MCV/Q is now in its tenth year of publication. Since its inception, its quality has shown
continual improvement and its circulation has quadrupled. Despite an increase in advertising revenue,
however, we are unable to meet the increased costs
of publication, and we are now faced with severe
budget restrictions. After this issue, therefore, our
gratis distribution will be limited to alumni, faculty,
and students of MCV/VCU, although we hope
that many of these readers will make voluntary
contributions or subscribe to the MCV/Q.
Regretfully, but with an eye to survival, we
must ask all others who wish to continue to receive
the MCV/Q, to subscribe at the prices quoted on
page 7. We hope that you regard this publication
as well worth the modest cost. To assure that you
do not miss the next issue, which will present a
second selection of the papers given at the McGuire
Lecture Series, and succeeding issues for this year,
presenting the 27th Annual Stoneburner Lectures
on "Clinical Advances in Medical and Surgical Neurology," please take a minute to complete the order
form provided herein and mail it as soon as possible.

47

A service to medical education from A. H. Robins:

theG. I.

Excerpted from Volume 2
of

S erles

on physical examination
of the abdomen :

Normally palpable organs:
the edge of the liver descending,
on inspiration, below the costal
margin (AJ ; the lower pole of the
right kidney (BJ; the abdominal
aorta (CJ; the descending colon
and the sigmoid (DJ; the ascending colon (EJ; and occasionally
the bladder (though rising of
this organ beyond the pubis
does not necessarily indicate
disease).
Impossible to outlin e, unless
diseased , distended or enlarged
the gallbladder, panc reas,
stomach, small intestin e, transverse colon and spleen

•·";;(ii.
' ~ S;..

. ·. ·1

consists of six bookThe A . H . Robins G.I. Series
lets. designed to provide a qu ick, ye t co m pre hen- [ , 1
s1ve review o f basic procedures and practices in
G .I. medicine - with particular emphasis on the
::::..,
physical examination as performed in the o ffice or '
"""·
at bedside . If you have teac hing responsibilitie s.
·-...
limited quantities a re available: Part 1 - lnspeclion ,
Part 2 - Palpation , Pa rt 3 - Percussion, Pa rt 4 - Auscultation , Part 5 Abdomina/ Pain and Part 6 - Differenl!al D iagnosis of Abdominal
Disorders. Write to : T he Medical Department, A. H . Robins Company,
1407 Cu mmings Drive. Richmond , Virginia 232 2 0.

I

A service to medical education from A. H. Robins:
Excerpted from Volume 2

oftheG. I.

Senes

on ph ysical examination
of the abdomen :

r~

-

.es ~.

The A.H . Robins G I Series consists of six booklets. designed to provide a quick . yet comprehen - ' . 1
sive review of basic procedures and practices in
G .I. medicine - with particular emphasis on the
~
physical examination as performed in the office or
' ......
at bed sid e . If you h ave teaching responsibilities
.......
limited quantities are available : Part 1 - Inspection.
Part 2 - Palpation . Part 3 - Percussion , Part 4 - Auscultation , Part 5 Abdominal Pain and Part 6 - Different1al Diagn osis of Abdominal
Disorders. Write to : The Medical Department , A.H . Robins Company,
14 07 Cummings Drive , Richmond . Vi rginia 23220 .
.. ,
:1'

.

I

!...

Normally palpable organs:
the edge of the liver descending ,
on inspiration , below the costal
margin (A) : the lower pole of the
right kidney (BJ: the abdominal
aorta (CJ ; the descending colon
and the sig moid (DJ: the ascending colon (EJ : and occasionall y
the bladder (th ough rising of
thi s organ beyond the pubis
does not necessa rily indicate
disease)
Im possible to outl ine, unless
diseased , distended or enlarged
the gallbladder, pancreas ,
stomach , small intestine, transverse colon and spleen .

each tablet.
capsule or 5 cc .
teaspoonful
of elixir
(23% alcohol)

each
Don natal
No. 2

each
Extentab

0.1037 mg .
hyoscyamine sulfate
o.3111 mg.
0 .1037mg.
0 .0194 mg .
0.0582mg.
atropine sulfate
0 .0194 mg.
0.0065 mg.
0.0 195mg.
hyoscine hydrobromide
0 .0065mg.
(V.. gr.) 16.2 mg . (Y.! gr.) 32.4 mg. (%gr.) 48.6 mg.
phenobarbital
(warning· may be habit forming)

•

Brief sum~ary. Adverse Reactions: Blurring of vision, dry mouth,
difficult urination, and flushing or dryness of the skin may occur
on higher dosage levels, rarely on usual dosage. Contraindications: Glaucoma; renal or hepatic disease;. obstructrve uropathy
(for example, bladder neck obstructiori due to prostatic hypertrophy); or hypersensitivity to any of the ingredients.

A·H·ROBI NS

A H. Robins Company. Richmond, Virginia 23220

each tablet,
capsule or 5 cc.
each
teaspoonful
each
' Donnatal
of elixir
Extentab
No.2
(23% alcohol)
0.3111 mg.
0.1037mg.
0.1037 mg.
hyoscyamine sulfate
0.0582mg.
0.0194 mg.
0.0194 mg.
atropine sulfate
00195mg.
0 .0065mg.
0.0065 mg.
hyoscine hydrobromide
(V• gr.) 16.2 mg. (Y.! gr.) 32.4 mg. (%gr.) 48.6 mg.
phenobarbital
(warning: may be habit forming)

•

Brief summary. Adverse Reactions: Blurring of vision, dry mouth,
difficult urination, and flushing or dryness of the skin may occur
on higher dosage levels, rarely on usual dosage, Contraindications: Glaucoma; renal or hepatic disease; obstructive uropathy
(for example, bladder neck obstruction due to prostatlc hypertrophy); or hypersensitivity to any of the ingredients.

A·H·ROB INS

A H Robins Company. Richmond, Virginia 23220

Before prescribing, please consult
complete product information, a summary of which follows:
Indications: Tension and anxiety

states, somatic complaints which are
concomitants of emotional factors; psychoneurotic states manifested by tension,
anxiety, apprehension, fatigue, depressive symptoms or agitation; symptomatic
relief of acute agitation, tremor, delirium
tremens and hallucinosis due to acute
alcohol withdrawal ; adjunctively in skeletal muscle spasm due to reflex spasm to
local pathology, spasticity caused by
upper motor neuron disorders, athetosis,
stiff-man syndrome, convulsive disorders
(not for.sole therapy) . ·
Contraindicated: Known hypersensitivity to the drug. Children under 6
months of age. Acute narrow angle glaucoma; may be used in patients with open
angle glaucoma who are receiving appropriate therapy.
Warnings: Not of value in psychotic
patients. Caution against hazardous
occupations requiring complete mental
alertness. When used adjunctively in convulsive disorders, possibility of increase
in frequency and/ or severity of grand mal
seizures may require increased dosage of
standard anticonvulsant medication;
abrupt withdrawal may be associated
with temporary increase in frequency
and/ or severity of seizures. Advise
against simultaneous ingestion of alcohol
and other CNS depressants. Withdrawal
symptoms (similar to those with barbiturates and alcohol) have occurred following abrupt discontinuance (convulsions,
tremor, abdominal and muscle cramps,
vomiting and sweating) . Keep addictionprone individuals under careful surveil:
lance because of their predisposition to ~r.
habituation and dependence. In preg\;:
nancy, lactation or women of childbearing
;,
age, weigh potential benefit against
possible hazard.
Precautions: If combined with other
psychotropics or anticonvulsants, consider carefully pharmacology of agents
employed; drugs such as phenothiazines,
narcotics, barbiturates, MAO inhibitors
and other antidepressants may potentiate
its action. Usual precautions indicated in
patients severely depressed, or with latent
depression, or with suicidal tendencies.
Observe usual precautions in impaired
renal or hepatic function. Limit dosage to
smallest effective amount in elderly and
debilitated to preclude ataxia or oversedation.
Side Effects: Drowsiness, confusion,
diplopia, hypotension, changes in libido,
nausea, fatigue, depression, dysarthria,
jaundice, skin rash, ataxia, constipation,
headache, incontinence, changes in salivation, slurred speech, tremor, vertigo,
urinary retention, blurred vision . Paradoxical reactions such as acute hyperexcited states, anxiety, hallucinations,
increased muscle spasticity, insomnia,
rage, sleep disturbances, stimulation
have been reported; should these occur,
discontinue drug. Isolated reports of neutropenia, jaundice; periodic blood counts
and liver function tests advisable during
long-term therapy.

Ifthere's good reason
to prescribe
for psychic tension...

.:J

When, in spite of counseling,
the patient's pattern ofoverreaction to stress
affects his ability to function

Dependable response
is a good reason
to considerValium

Roche Laboratories
. Division of Hoffmann-La Roche Inc .
Nutley, N.J. 07110

(diazepam)
2-mg,5-mg,
10-mg tablets

